Development of a novel trans-lentiviral vector that affords predictable safety.

@article{Wu2000DevelopmentOA,
  title={Development of a novel trans-lentiviral vector that affords predictable safety.},
  author={Xue-ling Wu and John K. Wakefield and Honglei Liu and Haixia Xiao and Robert Kralovics and Josef T Prchal and John C Kappes},
  journal={Molecular therapy : the journal of the American Society of Gene Therapy},
  year={2000},
  volume={2 1},
  pages={47-55}
}
Lentiviral vectors derived from human immunodeficiency virus type 1 (HIV-1) hold great promise for gene therapy. However, the possibility of generating replication-competent retrovirus (RCR) through genetic recombination raises concerns for safety. Here we describe a novel HIV-based packaging system (trans-lentiviral) that splits gag/gag-pol into two parts: One that expresses gag/gag-pro and another that expresses reverse transcriptase and integrase as fusion partners of viral protein R (Vpr… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 39 extracted citations

Risks Associated With Lentiviral Vector Exposures and Prevention Strategies

Journal of occupational and environmental medicine • 2016
View 1 Excerpt

Similar Papers

Loading similar papers…